The fate of antibodies bound to the surface of tumor cells in vitro
- PMID: 1737345
The fate of antibodies bound to the surface of tumor cells in vitro
Abstract
The fate of monoclonal antibodies binding to the surface of human tumor cells in vitro was investigated. Seven antibodies, labeled with 125I, were tested on four cell lines, which included a melanoma and carcinomas of the ovary, kidney, and lung. The antibodies were selected only by the criterion that they not be rapidly internalized via coated pits, so that they would be representative of most antibodies reacting with cell surface antigens. After allowing binding during a 2-h incubation, unbound antibody was removed, and the release of intact or degraded antibody in the supernatant was monitored. The data demonstrate that most bound antibody was gradually degraded and released from the cell over a 2-3-day period, probably via internalization, while only a small fraction, less than 20% for most antibodies, appeared to dissociate intact. One exceptional antibody, MW207, dissociated largely intact. The release of intact antibody was virtually complete within 4 h, and radioactivity released after this time was predominantly in degraded form. These results demonstrate that antibody binding to the surface of viable cells must in general be considered irreversible, and hence the concept of affinity is not applicable. Since an Fab fragment of one of the antibodies dissociated rapidly, such irreversible binding appears to require bivalent attachment. Another conclusion of this study is that most antibodies binding to the cell surface are gradually internalized, which we suggest is due to the normal turnover of cell surface constituents via non-clathrin-dependent endocytosis. Several experimental approaches indicated that a large fraction of antibody retained by the cells, for at least 2 days after binding, was present at the cell surface.
Similar articles
-
Blockade of Fc receptor-mediated binding to U-937 cells by murine monoclonal antibodies directed against a variety of surface antigens.J Immunol. 1983 Jul;131(1):140-7. J Immunol. 1983. PMID: 6223069
-
Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies.Anticancer Res. 1993 Nov-Dec;13(6A):2207-12. Anticancer Res. 1993. PMID: 8297135
-
Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.Cancer Res. 1987 Mar 15;47(6):1627-33. Cancer Res. 1987. PMID: 3545451
-
Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells.Cancer Res. 1987 Dec 15;47(24 Pt 1):6741-50. Cancer Res. 1987. PMID: 3677104
-
Distribution of monoclonal antiparathyroid antibody E11 in mice grafted with human parathyroid adenoma and carcinoma.Surgery. 1991 Nov;110(5):839-46. Surgery. 1991. PMID: 1948653
Cited by
-
Binding parameters of antibodies: pseudo-affinity and other misconceptions.Cancer Immunol Immunother. 2005 Jun;54(6):513-6. doi: 10.1007/s00262-004-0644-3. Epub 2004 Dec 31. Cancer Immunol Immunother. 2005. PMID: 15627210 Free PMC article.
-
The fate of antibodies and their radiolabels bound to tumor cells in vitro: the effect of cross-linking at the cell surface and of anti-idiotype antibodies.Cancer Immunol Immunother. 1994 Nov;39(5):325-31. doi: 10.1007/BF01519986. Cancer Immunol Immunother. 1994. PMID: 7987864 Free PMC article.
-
Antibody-Drug Conjugates and Targeted Treatment Strategies for Hepatocellular Carcinoma: A Drug-Delivery Perspective.Molecules. 2020 Jun 21;25(12):2861. doi: 10.3390/molecules25122861. Molecules. 2020. PMID: 32575828 Free PMC article. Review.
-
Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumors.Cancer Res. 2011 Mar 15;71(6):2250-9. doi: 10.1158/0008-5472.CAN-10-2277. Cancer Res. 2011. PMID: 21406401 Free PMC article.
-
Influence of cytokines, monoclonal antibodies and chemotherapeutic drugs on epithelial cell adhesion molecule (EpCAM) and LewisY antigen expression.Clin Exp Immunol. 2001 Jan;123(1):9-14. doi: 10.1046/j.1365-2249.2001.01435.x. Clin Exp Immunol. 2001. PMID: 11167991 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources